Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Patent Intelligence

Brokered Patent Market A summarized market report

One key takeaway from the Patent Brokered Market Report 2023 is that buyers held the upper hand in 2023, which is expected to continue in 2024. Price drops, particularly when

Drug Patent Infringement Cases Decoding the Latest Cases in the Pharma Industry

The pharmaceutical industry is known for its high-stakes drug patent infringement cases. Recently, several industry leaders, such as AbbVie, Bayer, and Cipla, have been involved in high-stakes litigation cases, garnering

Saving Millions With This Last Check Before The Patent Acquisition Deal

Acquiring highly valuable patents presents a significant opportunity to strengthen your patent portfolio and secure a competitive edge. However, what if, after acquiring the supposedly “gem patents,” you realize they

Power of Market Research Increasing the damages in Patent Infringement

Securing a ruling in your favor in an infringement case is a win, but translating that into a fair financial recovery is the real challenge. This scenario is all too

GreyB’s 3GPP Tool The Only Tool You Need To Determine Potential SEPs

Technical standards, evolving technologies, and scattered patent declarations complicate the process of determining standard essential patents (SEPs). This is further complicated by the need for manual searches across various databases,

Verifying Patent Infringement Potential Going beyond online literature

Online resources such as product manuals and company websites are a good starting point for patent infringement analysis. However, these sources can often be inconclusive, making it difficult to determine

The Ofev Patent Thicket Patents expiring in 2026

With an average life expectancy of 3-5 years after diagnosis, Pulmonary fibrosis highlights an urgent need for innovative therapeutic interventions. That’s where medications like Ofev have emerged as a transformative

Newracom’s Wi-Fi 6 Patent Portfolio A Dive Into Unacquired Assets & Their Potential

While early identification of Wi-Fi 7 SEPs is the long-term vision, immediate dominance in the wireless domain comes from identifying the sellers of Wi-fi 6 patents with enforceable portfolios. Wi-Fi

Building a Strong Wi-Fi 7 Patent Portfolio Here’s what you should know about

Major players like ZTE, Xiaomi, Zyxel, Sagemcom, Maxlinear, TP-Link, Buffalo, Gemtek, and a few others have already begun marketing their Wi-Fi 7 routers, following the certifications received from the Wi-Fi

AI Tools for Understanding Patents 4 AI Tools For Every IP Professional

Like every other industry, Artificial Intelligence (AI) has also transformed intellectual property (IP). With reduced human effort, patent experts can refine how they read, analyze, and leverage IP. Unsurprisingly, multiple

Trajenta Patent Thicket Patents expiring in 2025

Trajenta, known for its effective glycemic control without weight gain, is a key player in the diabetes medication sector. This critical medication, known generically as Linagliptin, is on the brink

Qi Standard Mapping Smart IP Licensing Move to Boost Revenue

IP Licensing is no longer a unique practice in dynamic technology domains. However, the key to success lies in finding the smartest and most creative strategy for analyzing infringement, which

New Searcher Standard For IPR Estoppel Strategic Considerations After The New Standard

Ironburg Inventions, known for its SCUF controllers, claimed that Valve’s Steam Controller infringed on its patents. Specifically, the patents in question were related to the back paddle design of controllers,

Optimizing SEP Licensing Strategy Quickly Identify Non-SEPs To Optimize Your SEP Licensing Strategy

Identifying Standard Essential Patents (SEPs) is a resource-intensive task, especially when dealing with a large patent portfolio. In this process, manual analysis is the preferred method, but examining patents that

Oppositions in Pharma Notable Recent Patent Oppositions in the Industry

The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these oppositions is crucial

Farxiga Patent Thicket Patents expiring in 2025

While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has been introduced